GPT and COVID-19: Evidence suggests that sepsis in COVID-19 contributes to hypoxic liver injury, causing a surge in liver biomarkers, which plausibly explains the higher levels of serum ALT, AST, and total bilirubin in severe COVID-19 patients relative to the non-severe group in our study [18,29].